Total Payments
$8,015
2024 Payments
$839.68
Companies
36
Transactions
396
Medicare Patients
1,137
Medicare Billing
$111,026
Payment Breakdown by Category
Food & Beverage$7,125 (88.9%)
Travel$818.11 (10.2%)
Education$72.37 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,125 | 383 | 88.9% |
| Travel and Lodging | $818.11 | 3 | 10.2% |
| Education | $72.37 | 6 | 0.9% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$8,015
392 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,197 | 127 | $0 (2024) |
| Boston Scientific Corporation | $994.20 | 7 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $700.96 | 46 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $576.02 | 37 | $0 (2024) |
| Celgene Corporation | $467.54 | 33 | $0 (2024) |
| Allergan Inc. | $360.21 | 10 | $0 (2019) |
| PFIZER INC. | $333.94 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $327.68 | 19 | $0 (2024) |
| Gilead Sciences, Inc. | $203.18 | 8 | $0 (2022) |
| GENZYME CORPORATION | $157.02 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $839.68 | 52 | ABBVIE INC. ($191.59) |
| 2023 | $699.29 | 43 | ABBVIE INC. ($173.39) |
| 2022 | $1,563 | 90 | Celgene Corporation ($208.06) |
| 2021 | $880.91 | 57 | AbbVie Inc. ($337.45) |
| 2020 | $624.88 | 38 | AbbVie Inc. ($210.47) |
| 2019 | $924.16 | 51 | AbbVie, Inc. ($259.92) |
| 2018 | $953.92 | 30 | AbbVie, Inc. ($393.51) |
| 2017 | $1,530 | 35 | BOSTON SCIENTIFIC CORPORATION ($641.46) |
All Payment Transactions
396 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: LIVER DISEASE | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Immunology | ||||||
| 11/05/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $95.91 | General |
| Category: LIVER DISEASE | ||||||
| 11/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/25/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: ONCOLOGY | ||||||
| 09/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Neuroscience | ||||||
| 09/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 332 | 555 | $185,509 | $39,233 |
| 2022 | 10 | 275 | 302 | $143,234 | $25,190 |
| 2021 | 11 | 242 | 264 | $115,108 | $21,503 |
| 2020 | 10 | 288 | 310 | $109,794 | $25,100 |
Total Patients
1,137
Total Services
1,431
Medicare Billing
$111,026
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 35 | 35 | $37,971 | $6,773 | 17.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 149 | $22,648 | $5,138 | 22.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 41 | $13,088 | $4,155 | 31.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 19 | 86 | $8,600 | $3,937 | 45.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 43 | 44 | $32,346 | $2,975 | 9.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 31 | $6,727 | $2,772 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,304 | $2,564 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 43 | $6,364 | $2,560 | 40.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 18 | $9,557 | $2,443 | 25.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 27 | 28 | $24,034 | $1,942 | 8.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 31 | $5,276 | $1,910 | 36.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,847 | $1,092 | 38.4% |
| 44361 | Biopsy of small bowel (except ileum) using an endoscope | Facility | 2023 | 14 | 14 | $8,748 | $972.81 | 11.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 27 | 28 | $29,748 | $4,916 | 16.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 34 | $9,989 | $3,484 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 57 | $8,436 | $3,445 | 40.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $9,296 | $2,994 | 32.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 38 | $32,702 | $2,666 | 8.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 31 | $6,727 | $2,635 | 39.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 33 | 34 | $24,043 | $1,521 | 6.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 24 | $3,778 | $1,213 | 32.1% |
| 44361 | Biopsy of small bowel (except ileum) using an endoscope | Facility | 2022 | 16 | 16 | $10,103 | $1,205 | 11.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 12 | 12 | $8,412 | $1,111 | 13.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 26 | 26 | $27,385 | $4,573 | 16.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 33 | $7,161 | $3,001 | 41.9% |
About Dr. Benjamin Kurz, MD
Dr. Benjamin Kurz, MD is a Gastroenterology healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2013. The National Provider Identifier (NPI) number assigned to this provider is 1710229596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Benjamin Kurz, MD has received a total of $8,015 in payments from pharmaceutical and medical device companies, with $839.68 received in 2024. These payments were reported across 396 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,125).
As a Medicare-enrolled provider, Kurz has provided services to 1,137 Medicare beneficiaries, totaling 1,431 services with total Medicare billing of $111,026. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Baton Rouge, LA
- Active Since 03/20/2013
- Last Updated 06/28/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1710229596
Products in Payments
- Humira (Biological) $877.35
- SPYSCOPE (Device) $615.97
- ZEPOSIA (Drug) $584.69
- XIFAXAN (Drug) $515.23
- HUMIRA (Biological) $501.70
- RINVOQ (Biological) $372.38
- ENTYVIO (Biological) $336.51
- XELJANZ (Drug) $333.94
- GENERAL POLYPECTOMY (Device) $327.14
- VIBERZI (Drug) $299.84
- STELARA (Biological) $239.54
- DUPIXENT (Biological) $203.45
- TRULANCE (Drug) $192.59
- OCALIVA (Drug) $146.62
- IBSRELA (Drug) $141.83
- Talicia (Drug) $122.00
- LINZESS (Drug) $118.08
- Linzess (Drug) $115.49
- MOTEGRITY (Drug) $105.33
- INJECTAFER (Drug) $97.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Baton Rouge
Neelima Reddy, Md, MD
Gastroenterology — Payments: $19,925
Gastroenterology $19,925
Dr. Gregory Gaspard, M.d, M.D
Gastroenterology — Payments: $19,177
Gastroenterology $19,177
Dr. Ronald Leo, M.d, M.D
Gastroenterology — Payments: $8,980
Gastroenterology $8,980
Dr. Walter Mullins, M.d, M.D
Gastroenterology — Payments: $7,593
Gastroenterology $7,593
Dr. Robert Be, M.d, M.D
Gastroenterology — Payments: $6,768
Gastroenterology $6,768
Gerald Arbour, M.d, M.D
Gastroenterology — Payments: $6,685
Gastroenterology $6,685